Generation Bio Co. - stock earnings
GBIO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 BeforeMarket | - / -0.3600000000 | - | - / 1.9 million | - |
GBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -35.2 million USD | 2.9 million USD |
| 2023Q3 | -28.3 million USD | 2.1 million USD |
| 2023Q2 | -31.1 million USD | 880000 USD |
| 2023Q1 | -28.0 million USD | ? USD |
| 2022Q4 | -30.1 million USD | ? USD |
| 2022Q3 | -29.9 million USD | ? USD |
| 2022Q2 | -37.4 million USD | ? USD |
| 2022Q1 | -34.7 million USD | ? USD |
| 2021Q4 | -30.9 million USD | ? USD |
| 2021Q3 | -31.9 million USD | ? USD |
| 2021Q2 | -30.8 million USD | ? USD |
| 2021Q1 | -25.6 million USD | ? USD |
| 2020Q4 | -24.2 million USD | ? USD |
| 2020Q3 | -20.8 million USD | ? USD |
| 2020Q2 | -17.7 million USD | ? USD |
| 2020Q1 | -17.7 million USD | ? USD |
| 2019Q4 | -16.1 million USD | ? USD |
| 2019Q3 | -16.1 million USD | ? USD |
| 2019Q2 | -15.0 million USD | ? USD |
| 2019Q1 | -14.1 million USD | ? USD |
GBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -126.6 million USD | 5.9 million USD |
| 2022 | -132.1 million USD | 880000 USD |
| 2021 | -114.7 million USD | ? USD |
| 2020 | -76.5 million USD | ? USD |
| 2019 | -60.3 million USD | ? USD |
| 2018 | -35.8 million USD | 36000 USD |
GBIO
Price: $3.06
52 week price:
Earnings Per Share: -1.96 USD
P/E Ratio: -0.93
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 16029
Market Capitalization: 210.8 million